Suppr超能文献

[吲哚菁绿血管造影引导下隐匿性脉络膜新生血管的激光光凝治疗。一项初步研究]

[Laser photocoagulation of occult choroidal neovascularization guided by angiography using indocyanine green. A pilot study].

作者信息

Donati G, Kapetanios A D, Pournaras C J

机构信息

Clinique Universitaire d'Ophtalmologie de Genève, Département des Neurosciences cliniques, Hôpitaux Universitaires de Genève, 1211 Genève 14, Suisse.

出版信息

J Fr Ophtalmol. 2000 Jan;23(1):45-51.

Abstract

PURPOSE

Age related macular degeneration (AMD) is the most common cause of legal blindness in the Western world in people over 50 years of age. The most severe visual loss occurs in patients with AMD complicated by choroidal neovascular membranes (CNV). Indocyanine green angiography (ICG) account for visualization in up to 60% of the cases that are classified as occult on fluorescein angiography (up to 70% of the cases). ICG-guided laser photocoagulation of CNV is currently a mater of debate. We conducted a pilot study to determine wether it could be beneficial for patients presenting with occult CNV on fluorescein angiography.

MATERIAL AND METHODS

Twenty consecutive patients (20 eyes) with occult CNV in AMD were included. All showed occult CNV on fluorescein angiography and a well defined juxta- or extrafoveal hot spot or plaque hyperfluorescence on ICG. Fibrovascular retinal pigment epithelial detachments were excluded. The patients had serial controls, including fluorescein angiography and ICG, at 15 days, 1, 2, 3, 6, 9 and 12 months after photocoagulation.

RESULTS

At the end of follow-up visual acuity (VA) was stable (within +/- 3 lines) compared to the initial one in 80% (16) of the cases. A complete resolution of exudative signs was observed in 75% (15) of the cases.

CONCLUSIONS

ICG-guided laser photocoagulation of occult CNV in AMD account for better visual acuity than natural course of the disease at 12 months follow-up. However, a prospective randomized clinical trial is warranted to evaluate definitively this treatment approach.

摘要

目的

年龄相关性黄斑变性(AMD)是西方世界50岁以上人群法定失明的最常见原因。最严重的视力丧失发生在合并脉络膜新生血管膜(CNV)的AMD患者中。吲哚菁绿血管造影(ICG)在荧光素血管造影分类为隐匿性的病例中,高达60%(高达70%的病例)可实现可视化。ICG引导下的CNV激光光凝目前存在争议。我们进行了一项初步研究,以确定其对荧光素血管造影显示为隐匿性CNV的患者是否有益。

材料与方法

纳入20例连续的AMD隐匿性CNV患者(20只眼)。所有患者在荧光素血管造影上均显示隐匿性CNV,在ICG上有明确的黄斑旁或黄斑外热点或斑块高荧光。排除纤维血管性视网膜色素上皮脱离。患者在光凝后15天、1、2、3、6、9和12个月进行系列检查,包括荧光素血管造影和ICG。

结果

随访结束时,80%(16例)患者的视力(VA)与初始视力相比保持稳定(在±3行以内)。75%(15例)患者的渗出性体征完全消退。

结论

在12个月的随访中,ICG引导下对AMD隐匿性CNV进行激光光凝,其视力比疾病自然病程更好。然而,需要进行一项前瞻性随机临床试验来最终评估这种治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验